contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


contextvision-mandatory-notification-of-trade-primary-insider-16

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

ContextVision is a medical technology company. The company specializes in image analysis and artificial intelligence. The company's products include advanced image enhancement software for ultrasound, MRI, X-ray and mammography. The software is used by hospitals and research institutes worldwide. The company was founded in 1983 and is headquartered in Stockholm.

ContextVision

STOCKHOLM - November 02 2022 - Gerald Pötzsch, CEO of ContextVision, has during the period of August 31[st] until November 1[st], 2022 purchased 10.000 shares in ContextVision AB at an average...

<pre>STOCKHOLM -&nbsp;November 02&nbsp;2022&nbsp;-&nbsp;Gerald Pötzsch, CEO of ContextVision, has during the period of August 31[st] until November 1[st], 2022 purchased 10.000&nbsp;shares in ContextVision AB at an average price of NOK&nbsp;8,71&nbsp;per share. After the transaction, Mr Pötzsch holds a total of&nbsp;15.000&nbsp;shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Gerald Pötzsch Relation to listed entity: CEO Trade:&nbsp;10.000 shares Date:&nbsp;01.11.2022 Average purchase price: NOK&nbsp;8,71&nbsp;per share Primary insider's total shareholdings post-purchase:&nbsp;15.000&nbsp;shares Primary insider's percentage shareholding post-purchase: 0,02% ### For further information, please contact ContextVision's CEO, Gerald Pötzsch,&nbsp;at +46&nbsp;8&nbsp;750 35 50 or gerald.potzsch@contextvision.com or visit&nbsp;www.contextvision.com&nbsp;(https://www.globenewswire.com/Tracker?data=3MaQGqfS t sB_Z2n6YL96mk -0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhV S qE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4 -54NJMeD5MzrIVSQFWmgmZB085ANCWw_ -3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaS X iPxhqyw==). ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X -ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting -edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX. </pre>